ARCHIVES

FASEB: Focus on Research Funding, Not PR

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

ACCC Workshop Set for Sept; Planning Grant Okd

June 6, 1975

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

March Dedicated To Colorectal Cancer Awareness; New Advocacy Group.

March 10, 2000

Bloch Pushes PDQ Promotion To Public, But NCAB Limits It to Physicians

February 17, 1984

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994